Cargando…

Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review

Breast cancer is one of the most common malignancies in women, with high morbidity and mortality rates. In breast cancer, the use of novel radiopharmaceuticals in nuclear medicine can improve the accuracy of diagnosis and staging, refine surveillance strategies and accuracy in choosing personalized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balma, Michele, Liberini, Virginia, Racca, Manuela, Laudicella, Riccardo, Bauckneht, Matteo, Buschiazzo, Ambra, Nicolotti, Daniele Giovanni, Peano, Simona, Bianchi, Andrea, Albano, Giovanni, Quartuccio, Natale, Abgral, Ronan, Morbelli, Silvia Daniela, D'Alessandria, Calogero, Terreno, Enzo, Huellner, Martin William, Papaleo, Alberto, Deandreis, Désirée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039137/ https://www.ncbi.nlm.nih.gov/pubmed/35492341 http://dx.doi.org/10.3389/fmed.2022.881551

Ejemplares similares

The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers
por: Liberini, Virginia, et al.
Publicado: (2021)

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
por: Liberini, Virginia, et al.
Publicado: (2022)

Applications of Artificial Intelligence and Radiomics in Molecular Hybrid Imaging and Theragnostics for Neuro-Endocrine Neoplasms (NENs)
por: Balma, Michele, et al.
Publicado: (2023)

NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
por: Liberini, Virginia, et al.
Publicado: (2021)

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
por: Bauckneht, Matteo, et al.
Publicado: (2019)

Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives
por: Bartolazzi, Armando, et al.
Publicado: (2018)

Surveys on COVID-19 in nuclear medicine: what happened and what we learned
por: Annunziata, Salvatore, et al.
Publicado: (2020)

The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
por: Santo, Giulia, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey
por: Annunziata, Salvatore, et al.
Publicado: (2020)

COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses—a Pitfall in [18F]FDG PET/CT
por: Liberini, Virginia, et al.
Publicado: (2021)

The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
por: Liberini, Virginia, et al.
Publicado: (2020)

The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study
por: Albano, Domenico, et al.
Publicado: (2019)

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
por: Laudicella, Riccardo, et al.
Publicado: (2019)

Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging
por: Morand, Grégoire B., et al.
Publicado: (2023)

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
por: Evangelista, Laura, et al.
Publicado: (2023)

BSREM for Brain Metastasis Detection with 18F-FDG-PET/CT in Lung Cancer Patients
por: Liberini, Virginia, et al.
Publicado: (2022)

Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy
por: Gosmann, Dario, et al.
Publicado: (2022)

Improved detection of in-transit metastases of malignant melanoma with BSREM reconstruction in digital [(18)F]FDG PET/CT
por: Liberini, Virginia, et al.
Publicado: (2021)

(18)F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival
por: Polverari, Giulia, et al.
Publicado: (2020)

The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Bauckneht, Matteo, et al.
Publicado: (2021)

A Semi Rigid Novel Hydroxamate AMPED-Based Ligand for (89)Zr PET Imaging
por: Russelli, Lisa, et al.
Publicado: (2021)

[(68)Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [(177)Lu]DOTATOC PRRT: The “Theragnomics” Concept
por: Laudicella, Riccardo, et al.
Publicado: (2022)

Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
por: Quartuccio, Natale, et al.
Publicado: (2020)

Basic physics of radiotracers
por: Barnes, W Earl
Publicado: (2017)

Impact of segmentation and discretization on radiomic features in (68)Ga-DOTA-TOC PET/CT images of neuroendocrine tumor
por: Liberini, Virginia, et al.
Publicado: (2021)

Can we produce an image of bacteria with radiopharmaceuticals?
por: Signore, A., et al.
Publicado: (2008)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Sonosensitive MRI Nanosystems as Cancer Theranostics: A Recent Update
por: Garello, Francesca, et al.
Publicado: (2018)

Radiotracers for the Central Serotoninergic System
por: Mangeant, Reynald, et al.
Publicado: (2022)

Diagnostic Value of Conventional PET Parameters and Radiomic Features Extracted from 18F-FDG-PET/CT for Histologic Subtype Classification and Characterization of Lung Neuroendocrine Neoplasms
por: Thuillier, Philippe, et al.
Publicado: (2021)

Combined forced diuresis and late acquisition on [(68)Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study
por: Bauckneht, Matteo, et al.
Publicado: (2023)

Evaluation of response to immune checkpoint inhibitors: Is there a role for positron emission tomography?
por: Bauckneht, Matteo, et al.
Publicado: (2017)

A Philosophy for CNS Radiotracer Design
por: Van de Bittner, Genevieve C., et al.
Publicado: (2014)

Current radiotracers to image neurodegenerative diseases
por: Tiepolt, Solveig, et al.
Publicado: (2019)

PET Imaging Radiotracers of Chemokine Receptors
por: Alluri, Santosh R., et al.
Publicado: (2021)

Radiotracers for Bone Marrow Infection Imaging
por: Jødal, Lars, et al.
Publicado: (2021)

Synthesis and Preclinical Evaluation of (177)Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
por: Wurzer, Alexander, et al.
Publicado: (2022)

Imaging of MSC transplantation in neuroscience
por: Filippi, Miriam, et al.
Publicado: (2017)

Synthesis and Optimization of the Labeling Procedure of (99m)Tc-Hynic-Interleukin-2 for In vivo Imaging of Activated T lymphocytes
por: D’Alessandria, Calogero, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_k9tj0fblvuu6n8748i11ttg6rm